| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.55 | 0.05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.18 | 0.0003 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.17 | 0.004 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |